Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Location is everything when it comes to megakaryocyte function
Eric Boilard, Kellie R. Machlus
Eric Boilard, Kellie R. Machlus
Published January 4, 2021
Citation Information: J Clin Invest. 2021;131(1):e144964. https://doi.org/10.1172/JCI144964.
View: Text | PDF
Commentary Article has an altmetric score of 14

Location is everything when it comes to megakaryocyte function

  • Text
  • PDF
Abstract

Megakaryocytes (MKs) give rise to platelets, which are blood cells that are essential to prevent hemorrhage. Although the majority of MKs localize to the bone marrow, there is a distinct population of lung-residing MKs (MKL). In this issue of the JCI, Pariser et al. examined gene expression patterns of MKs collected from murine and nonhuman primate bone marrow or lung. This Commentary explores the premise that environmental factors from the lung determine the genetic and phenotypic similarity of MKL to lung dendritic cells, distinguishing MKL from bone marrow MKs. Indeed, while MKL retain the ability to make platelets, they also process and present antigens that activate CD4+ lymphocytes. These data suggest that MKL may play an important role in immune processes beyond platelet production.

Authors

Eric Boilard, Kellie R. Machlus

×

Total citations by year

Year: 2025 2024 2023 2022 2021 Total
Citations: 1 3 1 3 4 12
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (12)

Title and authors Publication Year
Cause of Death Analysis in a 9½-Year-Old with COVID-19 and Dravet Syndrome
Meher VR, Huntsman RJ, Green FH, Wooff JC, Auer RN
Pathophysiology 2025
Understanding Megakaryocyte Phenotypes and the Impact on Platelet Biogenesis
Chen S, Looney MR
Transfusion 2024
Immunological face of megakaryocytes.
Li Y, Chen K, Wang QF
Frontiers of medicine 2024
Megakaryocyte in sepsis: the trinity of coagulation, inflammation and immunity
Hua T, Yao F, Wang H, Liu W, Zhu X, Yao Y
Critical Care 2024
Eosinophils in the tumor microenvironment: implications for cancer immunotherapy.
Ghaffari S, Rezaei N
Journal of Translational Medicine 2023
Megakaryocyte Diversity in Ontogeny, Functions and Cell-Cell Interactions
E Khatib-Massalha, S Méndez-Ferrer
Frontiers in Oncology 2022
小鼠原代巨核细胞骨髓腔移植模型的构建
2022
CXCR4high megakaryocytes regulate host-defense immunity against bacterial pathogens
Wang J, Xie J, Wang D, Han X, Chen M, Shi G, Jiang L, Zhao M
eLife 2022
A Novel Megakaryocyte Subpopulation Poised to Exert the Function of HSC Niche as Possible Driver of Myelofibrosis
AR Migliaccio
Cells 2021
The heterogeneity of megakaryocytes and platelets and implications for ex vivo platelet generation
C Liu, B Huang, H Wang, J Zhou
Stem Cells Translational Medicine 2021
Role of Rho-GTPases in megakaryopoiesis
W Vainchenker, B Arkoun, F Basso-Valentina, L Lordier, N Debili, H Raslova
Small GTPases 2021
Toward platelet transcriptomics in cancer diagnosis, prognosis and therapy
A Krishnan, S Thomas
British Journal of Cancer 2021

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Posted by 21 X users
On 1 Facebook pages
29 readers on Mendeley
See more details